Abstract:Background & Aims: Alterations of multiple metabolites characterize distinct features of metabolic reprograming in hepatocellular carcinoma (HCC). However, the role of most metabolites, including propionyl-CoA (Pro-CoA), in metabolic reprogramming and hepatocarcinogenesis remains elusive. In this study, we aimed to dissect how Pro-CoA metabolism affects these processes.Methods: TCGA data and HCC samples were used to analyze ALDH6A1-mediated Pro-CoA metabolism and its correlation with HCC. Multiple metabolites were assayed by targeted mass spectrometry. The role of ALDH6A1-generated Pro-CoA in HCC was evaluated in HCC cell lines as well as xenograft nude mouse models and primary liver cancer mouse models. Non-targeted metabolomic and targeted energy metabolomic analyses, as well as multiple biochemical assays, were performed.Results: Decreases in Pro-CoA and its derivative propionyl-L-carnitine due to ALDH6A1 downregulation were tightly associated with HCC. Functionally, ALDH6A1-mediated Pro-CoA metabolism suppressed HCC proliferation in vitro and impaired hep-atocarcinogenesis in mice. The aldehyde dehydrogenase activity was indispensable for this function of ALDH6A1, while Pro-CoA carboxylases antagonized ALDH6A1 function by eliminating Pro-CoA. Mechanistically, ALDH6A1 caused a signature enrichment of central carbon metabolism in cancer and impaired energy metabolism: ALDH6A1-generated Pro-CoA suppressed citrate synthase activity, which subsequently reduced tricarboxylic acid cycle flux, impaired mitochondrial respiration and membrane potential, and decreased ATP production. Moreover, Pro-CoA metabolism generated 2-methylcitric acid, which mimicked the inhibitory effect of Pro-CoA on citrate synthase and dampened mitochondrial respiration and HCC proliferation.Conclusions: The decline of ALDH6A1-mediated Pro-CoA metabolism contributes to metabolic remodeling and facilitates hep-atocarcinogenesis. Pro-CoA, propionyl-L-carnitine and 2-methylcitric acid may serve as novel metabolic biomarkers for the diag-nosis and treatment of HCC. Pro-CoA metabolism may provide potential targets for development of novel strategies against HCC.(c) 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

METABOLIC PROFILING ANALYSIS UPON ACYLCARNITINES IN TISSUES OF HEPATOCELLULAR CARCINOMA REVEALED THE INHIBITED CARNITINE SHUTTLE SYSTEM CAUSED BY THE DOWNREGULATED CARNITINE PALMITOYLTRANSFERASE 2.

Dysregulated Serum Metabolites in Staging of Hepatocellular Carcinoma.

Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma

A Specific Cholesterol Metabolic Pathway is Established in a Subset of HCCs for Tumor Growth

OCTN2 enhances PGC-1α-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma

Aberrant Lipid Metabolism In Hepatocellular Carcinoma Revealed By Liver Lipidomics

Functional Lipidomics: Palmitic Acid Impairs Hepatocellular Carcinoma Development by Modulating Membrane Fluidity and Glucose Metabolism

Simultaneously Targeting SOAT1 and CPT1A Ameliorates Hepatocellular Carcinoma by Disrupting Lipid Homeostasis

Effects of Carnitine Palmitoyltransferases on Cancer Cellular Senescence

Lipidomics Reveals Carnitine Palmitoyltransferase 1C Protects Cancer Cells from Lipotoxicity and Senescence

Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming

Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated with Progression of Hepatocellular Carcinoma and Patient Outcomes

Identification of Acetyl-Coa Carboxylase Alpha As a Prognostic and Targeted Candidate for Hepatocellular Carcinoma.

Decreased Propionyl-Coa Metabolism Facilitates Metabolic Reprogramming and Promotes Hepatocellular Carcinoma.

Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC

CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer

Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation

Prognostic Significance of Two Lipid Metabolism Enzymes, HADHA and ACAT2, in Clear Cell Renal Cell Carcinoma

Serum Metabolomics Reveals the Deregulation of Fatty Acids Metabolism in Hepatocellular Carcinoma and Chronic Liver Diseases

Carnitine palmitoyltransferase 1c and its role in carcinogenesis